Carregant...
Effect of Obesity on Clinical Outcomes of Patients Treated With Cefepime
Background: As the prevalence of obesity climbs, dosing of antimicrobials, particularly cephalosporins, is becoming a greater challenge for clinicians. Data are lacking for appropriate dosing of cefepime, an anti-pseudomonal cephalosporin that is widely used as an empiric anti-pseudomonal agent. Obj...
Guardat en:
| Publicat a: | J Pharm Technol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809331/ https://ncbi.nlm.nih.gov/pubmed/34752550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122520967398 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|